Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Huaheng Biotech: Updated submission for H-share listing application on the Main Board of the Hong Kong Stock Exchange
Mars Finance News, May 5th: Huaheng Biological announced that the company is advancing the issuance of overseas-listed shares (H-shares) and listing on the Main Board of the Hong Kong Stock Exchange. The application was submitted on September 30, 2025, and updated on April 30, 2026, with relevant updates published on the HKEX website. The application materials are draft versions, and the information contained may be updated or revised. The target investors for this issuance are qualified investors both overseas and domestically. Overseas issuance and listing are still subject to approval by relevant regulatory authorities and stock exchanges, and there is uncertainty. (Company Announcement)